IPCA LABORATORIES : AMALGAMATION APPROVED WITH KREBS BIOCHEMICALS & INDUSTRIES LTD.

• Board approves scheme of amalgamation of Krebs Biochemicals & Industries Ltd. with Ipca Laboratories Ltd., a related party transaction at arm's length. • Both entities are engaged in pharmaceuticals manufacturing and marketing, aiming for operational synergies, cost optimization, and business consolidation. • No cash consideration; Ipca to issue 7 equity shares of Re. 1/- each for every 200 equity shares of Rs. 10/- each in Krebs. • Promoter shareholding in the amalgamated company to reduce slightly from 44.72% to 44.66%, while public shareholding increases from 55.28% to 55.34%. • Impact: Consolidation of pharmaceutical business and potential for improved operational efficiencies.

Ipca Laboratories Ltd

Open attachment

← Back to feed